We are live on ! Find out more
BXRX

Baudax Bio, Inc. Common Stock
BXRX

Delisted

BXRX was delisted on the 15th of November, 2023.

Back to rankings

31 hedge funds and large institutions have $9.43M invested in Baudax Bio, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

756% more call options, than puts

Call options by funds: $899K | Put options by funds: $105K

125% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 4

49% more capital invested

Capital invested by funds: $6.34M → $9.43M (+$3.09M)

9% less funds holding

Funds holding: 34 → 31 (-3)

23% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 13

Holders
31
Holders Change
-3
Holders Change %
-8.82%
% of All Funds
0.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
9
Reduced
4
Closed
13
Calls
$899K
Puts
$105K
Net Calls
+$794K
Net Calls Change
+$734K

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$4.85M
2
BlackRock
BlackRock
New York
+$1.82M
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$482K
4
Two Sigma Advisers
Two Sigma Advisers
New York
+$190K
5
Northern Trust
Northern Trust
Illinois
+$150K

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$3.54M
2
Renaissance Technologies
Renaissance Technologies
New York
-$426K
3
GCP
GSA Capital Partners
United Kingdom
-$290K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$256K
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$134K
Name Holding Trade Value Shares
Change 		Change in
Stake
Group One Trading
26
Group One Trading
Illinois
$10K +$2K +1 +25%
FDCDDQ
27
Federation des caisses Desjardins du Quebec
Quebec, Canada
$3.23K -$2K -1 -33%
Morgan Stanley
28
Morgan Stanley
New York
$3K – – –
Wells Fargo
29
Wells Fargo
California
$2K -$2K -1 -50%
SN
30
Sittner & Nelson
Oregon
$2K – – –
Royal Bank of Canada
31
Royal Bank of Canada
Ontario, Canada
$1K -$12K -6 Closed
JP Morgan Chase
32
JP Morgan Chase
New York
$1K – – –
HWM
33
HighMark Wealth Management
Minnesota
$1K +$2K +1 New
SPIA
34
Steward Partners Investment Advisory
New York
$645 – – –
AC
35
Armistice Capital
New York
– -$3.54M -2,505 Closed
Renaissance Technologies
36
Renaissance Technologies
New York
– -$426K -302 Closed
Susquehanna International Group
37
Susquehanna International Group
Pennsylvania
– -$256K -128 Closed
D.E. Shaw & Co
38
D.E. Shaw & Co
New York
– -$134K -95 Closed
CCM
39
Corsair Capital Management
New York
– -$92K -65 Closed
Alyeska Investment Group
40
Alyeska Investment Group
Illinois
– -$82K -58 Closed
HWA
41
HCR Wealth Advisors
California
– -$15K -11 Closed
ASN
42
Advisory Services Network
Georgia
– -$13K -9 Closed
DAS
43
Dynamic Advisor Solutions
Arizona
– -$12K -8 Closed
PPA
44
Parametric Portfolio Associates
Washington
– -$11K -8 Closed
Simplex Trading
45
Simplex Trading
Illinois
– -$2K -1 Closed
TRCT
46
Tower Research Capital (TRC)
New York
– -$2K -1 Closed
1
2

BXRX Hedge Fund Activity: Q1 2021 in Review

31 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Baudax Bio, Inc. Common Stock (BXRX) for Q1 2021, worth a combined $9.43M — up 49% from $6.34M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of BXRX and 10 opened new positions — a net loss of 3 holders — while 4 trimmed existing stakes and 9 added.

The largest buyer was Vanguard Group, adding an estimated $4.85M. The largest seller was Armistice Capital, exiting entirely with an estimated $3.54M sold.

  • 31 institutional investors held Baudax Bio, Inc. Common Stock (BXRX) as of Q1 2021, down from 34 in Q4 2020.
  • Funds reported $9.43M of Baudax Bio, Inc. Common Stock stock for Q1 2021, up 49% quarter-over-quarter.
  • 10 funds opened new Baudax Bio, Inc. Common Stock positions in Q1 2021 and 13 closed out, a net change of -3 holders.
  • The largest Baudax Bio, Inc. Common Stock buyer in Q1 2021 was Vanguard Group, an estimated $4.85M added.
  • The largest Baudax Bio, Inc. Common Stock seller in Q1 2021 was Armistice Capital, an estimated $3.54M sold.

Based on aggregated 13F filings for Q1 2021.